National Comprehensive Cancer Network



About NCCN

Bladder/Penile Cancers Panel - Disclosures as of 8/29/2012

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Neeraj Agarwal, MD

None

None

None

None

8/3/2012

Matthew C. Biagioli, MD, MS

None

None

None

None

10/16/2012

Peter E. Clark, MD

None

Archimedes

None

None

8/28/2012

Mary Dwyer, MS

None

None

None

None

3/26/2013

Mario A. Eisenberger, MD

None

Bristol-Myers Squibb Company;
genvec;
Ipsen

Johnson & Johnson

None

8/31/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Richard E. Greenberg, FACS, MD

None

Endo Pharmaceuticals

None

None

3/26/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Harry W. Herr, MD

None

None

None

None

8/28/2012

Maria Ho, PhD

None

None

None

None

8/3/2012

Brant A. Inman, MD, MSc

GlaxoSmithKline

None

None

None

8/28/2012

Deborah A. Kuban, MD

None

None

Immtech International, Inc.

None

8/28/2012

Timothy M. Kuzel, MD

Bayer HealthCare;
Bristol-Myers Squibb Company;
CureTech Ltd.;
Eli Lilly and Company;
GlaxoSmithKline;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Alton Pharmaceuticals;
ARgos Therapeutics;
Biovex, Inc

Celgene Corporation;
Exelixis Inc.;
Genentech, Inc.;
GlaxoSmithKline;
Jannsen Pharmaceutica Products, LP;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Affymax;
Aveo Pharma;
Prometheus Laboratories

None

None

8/28/2012

Subodh M. Lele, MD

None

None

None

None

8/28/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

Jeff Michalski, MD, MBA

None

None

None

None

8/13/2012

Lance C. Pagliaro, MD

None

None

None

None

1/4/2013

Sumanta K. Pal, MD

None

Genentech, Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
sanofi-aventis U.S.

None

None

3/27/2012

Anthony Patterson, MD

None

None

None

None

8/15/2012

Elizabeth R. Plimack, MD, MS

None

None

None

None

10/17/2012

Kamal S. Pohar, MD

None

None

None

None

9/27/2012

Michael P. Porter, MD, MS

None

None

None

None

4/29/2013

Jerome Paul Richie, MD

None

None

None

None

4/29/2013

Wade Jeffers Sexton, MD

Endo Pharmaceuticals

Endo Pharmaceuticals

None

None

8/3/2012

William U. Shipley, MD, FACR

None

None

Pfizer Inc.

None

8/28/2012

Eric J. Small, MD

None

None

None

None

9/24/2012

Philippe E. Spiess, MD

None

None

None

None

4/29/2013

Donald L. Trump, MD

None

None

None

None

5/17/2012

Geoffrey Wile, MD

None

None

None

None

6/13/2012

Timothy G. Wilson, MD

None

Covidien

None

None

1/6/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved